Detalhe da pesquisa
1.
PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation.
Front Oncol
; 14: 1380633, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807759
2.
Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
J Drug Target
; 13(3): 151-9, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16036303
3.
Prolonged cytotoxic effect of colchicine released from biodegradable microspheres.
J Biomed Mater Res B Appl Biomater
; 71(2): 295-304, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15386399
4.
Evaluating TBK1 as a therapeutic target in cancers with activated IRF3.
Mol Cancer Res
; 12(7): 1055-66, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752990
5.
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
PLoS One
; 7(9): e44455, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973452
6.
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells.
Mol Cancer Ther
; 11(11): 2451-61, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869555
7.
The use of antibodies in diagnosis and therapy of cancer.
Adv Exp Med Biol
; 534: 309-25, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12903729
8.
Hepatocyte growth factor regulates the development of highly pure cultured chief cells from rat stomach by stimulating chief cell proliferation in vitro.
Am J Physiol Gastrointest Liver Physiol
; 296(2): G319-29, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19023030